CareCloud (CCLD) Q2 2026 Earnings Report

The call presents a constructive, strategic story: solid top-line growth (+16% Q2, +15% H1), a growing recurring revenue mix, continued GAAP profitability streak, a cleaner capital structure after fully redeeming Series B, and clear progress on AI and a new compliance SaaS initiative. Near-term reported profitability and some cash metrics are pressured by deliberate investment choices — accelerated R&D expense, acquisition-related amortization, and higher interest — and by integration work (notably Medsphere). Management reaffirmed guidance and expects a stronger second half as investments convert to scale. Overall, positives (revenue/regional trends, recurring revenue expansion, capital structure improvement, AI/product milestones, new market entry) outweigh the near-term headwinds driven by strategic investments and integration costs, but execution risk remains.

CareCloud reaffirmed full‑year 2026 guidance of $128.0–$132.0 million in revenue, $29–$31 million of adjusted EBITDA, and GAAP EPS of $0.20–$0.23. In the first half the company reported $63.2 million of revenue (Q2 revenue $31.9M, +16% YoY), recurring technology‑enabled revenue of about $24.0M in Q2 (~75% of revenue), GAAP net income of $2.0M YTD ($1.1M in Q2), adjusted EBITDA of $11.3M YTD ($5.9M in Q2), adjusted net income of $4.5M YTD ($2.4M or $0.06/share in Q2) and $8.1M of free cash flow YTD. The guidance implies a materially stronger second half (roughly $64.8–$68.8M of revenue remaining, or about $32.4–$34.4M per quarter, and about $17.7–$19.7M of adjusted EBITDA needed in H2), benefits from the May 15 redemption of Series B (eliminating ~$3.3M of annual preferred dividends starting Q3 and funded by a $50M credit facility), and a balance sheet with ~$13.4M cash, ~$695K net working capital and a $60M ATM; achievement remains contingent on client signings, project timing and integration/expense execution.